26.80
price down icon4.83%   -1.36
after-market Dopo l'orario di chiusura: 26.85 0.05 +0.19%
loading
Precedente Chiudi:
$28.16
Aprire:
$27.72
Volume 24 ore:
2.84M
Relative Volume:
0.73
Capitalizzazione di mercato:
$3.01B
Reddito:
-
Utile/perdita netta:
$-99.15M
Rapporto P/E:
-28.82
EPS:
-0.93
Flusso di cassa netto:
$-74.25M
1 W Prestazione:
-0.67%
1M Prestazione:
-4.08%
6M Prestazione:
-49.38%
1 anno Prestazione:
-56.62%
Intervallo 1D:
Value
$26.55
$27.73
Intervallo di 1 settimana:
Value
$26.55
$28.33
Portata 52W:
Value
$18.92
$81.73

Viking Therapeutics Inc Stock (VKTX) Company Profile

Name
Nome
Viking Therapeutics Inc
Name
Telefono
858-704-4660
Name
Indirizzo
9920 PACIFIC HEIGHTS BLVD, SUITE 350, SAN DIEGO, CA
Name
Dipendente
46
Name
Cinguettio
@viking_vktx
Name
Prossima data di guadagno
2024-10-23
Name
Ultimi documenti SEC
Name
VKTX's Discussions on Twitter

Confronta VKTX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
VKTX
Viking Therapeutics Inc
26.80 3.03B 0 -99.15M -74.25M -0.93
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

Viking Therapeutics Inc Stock (VKTX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-29 Iniziato Cantor Fitzgerald Overweight
2025-04-08 Iniziato Goldman Neutral
2025-02-13 Iniziato Scotiabank Sector Outperform
2025-02-07 Iniziato Citigroup Neutral
2024-12-02 Iniziato Piper Sandler Overweight
2024-11-22 Iniziato B. Riley Securities Buy
2024-11-04 Reiterato H.C. Wainwright Buy
2024-09-11 Iniziato JP Morgan Overweight
2024-06-27 Iniziato Morgan Stanley Overweight
2024-05-16 Aggiornamento Raymond James Outperform → Strong Buy
2024-03-26 Reiterato Oppenheimer Outperform
2024-03-07 Iniziato Jefferies Buy
2024-02-28 Reiterato Oppenheimer Outperform
2023-05-31 Ripresa ROTH MKM Buy
2023-03-28 Reiterato Maxim Group Buy
2023-03-17 Iniziato Stifel Buy
2021-07-29 Ripresa BTIG Research Buy
2021-05-25 Downgrade Raymond James Strong Buy → Outperform
2020-06-05 Iniziato BMO Capital Markets Outperform
2020-05-05 Iniziato Chardan Capital Markets Buy
2020-05-01 Iniziato BTIG Research Buy
2019-07-16 Iniziato Oppenheimer Outperform
2019-06-25 Iniziato Stifel Buy
2019-03-29 Aggiornamento SVB Leerink Mkt Perform → Outperform
2019-03-14 Reiterato Maxim Group Buy
2019-02-22 Iniziato SVB Leerink Mkt Perform
2018-12-12 Iniziato B. Riley FBR Buy
2018-11-19 Aggiornamento Raymond James Outperform → Strong Buy
2018-09-18 Reiterato H.C. Wainwright Buy
2018-09-18 Reiterato Maxim Group Buy
2018-09-18 Reiterato Raymond James Outperform
2018-07-20 Iniziato SunTrust Buy
2018-06-28 Iniziato Raymond James Outperform
2018-06-01 Reiterato Laidlaw Buy
2018-05-31 Reiterato Maxim Group Buy
2018-03-26 Ripresa H.C. Wainwright Buy
2017-11-28 Reiterato Maxim Group Buy
2017-11-21 Iniziato ROTH Capital Buy
Mostra tutto

Viking Therapeutics Inc Borsa (VKTX) Ultime notizie

pulisher
May 30, 2025

Novo Nordisk vs. Viking Therapeutics: Which GLP-1 Stock Has More Upside? - MSN

May 30, 2025
pulisher
May 30, 2025

Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Street's Bullish Views? - Yahoo Finance

May 30, 2025
pulisher
May 29, 2025

SA analyst upgrades: NVDA, DJT, VKTX, BRK.A, BEAM (NVDA:NASDAQ) - Seeking Alpha

May 29, 2025
pulisher
May 29, 2025

Viking Therapeutics: Obesity Candidates Must Prove Their Edge As Market Matures (Upgrade) - Seeking Alpha

May 29, 2025
pulisher
May 28, 2025

Viking Therapeutics to Participate at Upcoming Investor Conferen - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Viking Therapeutics to Participate at Upcoming Investor Conferences | VKTX Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Viking Therapeutics Lines Up Presentations at Goldman Sachs, William Blair Healthcare Conferences - Stock Titan

May 28, 2025
pulisher
May 27, 2025

Viking Therapeutics Holds Annual Stockholders Meeting - TipRanks

May 27, 2025
pulisher
May 27, 2025

Viking Therapeutics: Buy It For The Future And Ignore The Noise (NASDAQ:VKTX) - Seeking Alpha

May 27, 2025
pulisher
May 25, 2025

(VKTX) On The My Stocks Page - news.stocktradersdaily.com

May 25, 2025
pulisher
May 24, 2025

Better Weight Loss Stock: Amgen or Viking Therapeutics? - MSN

May 24, 2025
pulisher
May 22, 2025

Viking Therapeutics: Weight-Loss Story Remains Intact (NASDAQ:VKTX) - Seeking Alpha

May 22, 2025
pulisher
May 22, 2025

Bank of America Corp DE Reduces Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX) - Defense World

May 22, 2025
pulisher
May 21, 2025

Will Pfizer Will Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback? - AOL.com

May 21, 2025
pulisher
May 20, 2025

Viking Therapeutics: A High Potential Biotech Play With Manageable Risks (NASDAQ:VKTX) - Seeking Alpha

May 20, 2025
pulisher
May 20, 2025

Viking Therapeutics: Near-Term Catalysts And Competitor Readouts - Seeking Alpha

May 20, 2025
pulisher
May 18, 2025

BNP Paribas Financial Markets Has $1.88 Million Stock Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX) - Defense World

May 18, 2025
pulisher
May 17, 2025

Viking Therapeutics (VKTX) Stock Rises Amid Novo Nordisk CEO Cha - GuruFocus

May 17, 2025
pulisher
May 17, 2025

Why Viking Therapeutics Stock Bumped 3% Higher Today - Mitrade

May 17, 2025
pulisher
May 15, 2025

When (VKTX) Moves Investors should Listen - news.stocktradersdaily.com

May 15, 2025
pulisher
May 14, 2025

Viking Therapeutics Stock May Struggle After As-Expected Report - MSN

May 14, 2025
pulisher
May 13, 2025

2 Monster Stocks in the Making to Buy Now and Hold for 10 Years - The Motley Fool

May 13, 2025
pulisher
May 13, 2025

Dimensional Fund Advisors LP Has $4.06 Million Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX) - Defense World

May 13, 2025
pulisher
May 12, 2025

Viking Therapeutics, Inc. (NASDAQ:VKTX) Given Average Recommendation of “Buy” by Analysts - Defense World

May 12, 2025
pulisher
May 11, 2025

Viking Therapeutics Q1 Loss Wider Than Expected, Sales Nil, Stock Dips - The Globe and Mail

May 11, 2025
pulisher
May 11, 2025

3 Monster Stocks in the Making - Yahoo Finance

May 11, 2025
pulisher
May 11, 2025

Hsbc Holdings PLC Sells 9,437 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX) - Defense World

May 11, 2025
pulisher
May 06, 2025

Why Viking Therapeutics (VKTX) Stock is Gaining Today - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Why Viking Therapeutics Stock Surged Nearly 20% Higher in April - Yahoo

May 06, 2025
pulisher
May 05, 2025

Viking Therapeutics (VKTX) Sees Unusual Options Activity | VKTX Stock News - GuruFocus

May 05, 2025
pulisher
May 05, 2025

Why Viking Therapeutics Stock Surged Nearly 20% Higher In April - Barchart.com

May 05, 2025
pulisher
May 05, 2025

Why Viking Therapeutics Stock Was Victorious This Week - MSN

May 05, 2025
pulisher
May 05, 2025

(VKTX) Investment Report - news.stocktradersdaily.com

May 05, 2025
pulisher
May 04, 2025

Viking Therapeutics (VKTX) Sees 20% Stock Surge Despite Financial Losses - GuruFocus

May 04, 2025
pulisher
May 02, 2025

Why Viking Therapeutics (VKTX) Stock is Rising Today - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Viking Therapeutics call volume above normal and directionally bullish - TipRanks

May 02, 2025
pulisher
May 02, 2025

Viking Therapeutics (VKTX) Sees Surge in Call Options Trading | VKTX Stock News - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Viking Therapeutics (NasdaqCM:VKTX) Reports Increased Net Loss of US$46 Million in Q1 2025 - simplywall.st

May 02, 2025
pulisher
May 02, 2025

Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday - The Globe and Mail

May 02, 2025
pulisher
May 02, 2025

This Soaring Stock Just Delivered More Good News. Time to Buy? - AOL.com

May 02, 2025
pulisher
May 02, 2025

Where Will Viking Therapeutics Be in 3 Years? - Yahoo Finance

May 02, 2025

Viking Therapeutics Inc Azioni (VKTX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
Capitalizzazione:     |  Volume (24 ore):